PBS Biotech develops and enhances single-use bioreactor systems and bioprocess development services to improve the production of therapeutic cells for regenerative medicines.

Pluristyx is a company that provides gene-edited induced pluripotent stem cell (iPSC) lines and cell therapy development tools and services to accelerate the clinical trial and commercialization process for stem cell therapeutic companies.